Contribution of research networks to a clinical trial of antidepressants in people with dementia.

Autor: McCrae N; Florence Nightingale School of Nursing & Midwifery, King's College London, Room 1.17, James Clerk Maxwell Building, London, UK. n.mccrae@kcl.ac.uk, Douglas L, Banerjee S
Jazyk: angličtina
Zdroj: Journal of mental health (Abingdon, England) [J Ment Health] 2012 Oct; Vol. 21 (5), pp. 439-47. Date of Electronic Publication: 2012 May 01.
DOI: 10.3109/09638237.2012.664298
Abstrakt: Background: The Mental Health Research Network and Dementia and Neurodegenerative Diseases Research Network were established in the UK to increase research capacity and activity; the former in mental health generally, and the latter specifically in neurodegenerative disorders including dementia. Little evidence exists on the impact of these networks on research in mental health of older people.
Aims: To examine research network support to a multi-centre randomised controlled trial of antidepressants in people with depression superimposed on dementia. Method Qualitative questionnaires were completed by principal investigators, trial-funded research workers and clinical study officers (CSOs) of the research networks.
Results: Research network contribution was much valued by principal investigators and the nine research teams. CSOs boosted the recruitment campaign in a challenging environment and enhanced assessment processes. Some problems with consistency and staff turnover were raised.
Conclusion: Research network input can make an appreciable difference to the process and outcome of a multi-centre clinical trial.
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje